# Evaluating Clinical Outcomes of Targeted Radiofrequency Ablation and Kyphoplasty (Also Known as Vertebral Augmentation) to Treat Painful Metastatic Vertebral Body Tumors

> **NCT02081053** · NA · TERMINATED · sponsor: **DFINE Inc.** · enrollment: 30 (actual)

## Conditions studied

- Metastatic Lesions in Vertebral Bodies

## Interventions

- **DEVICE:** STAR™ Tumor Ablation System and StabiliT® Vertebral Augmentation System

## Key facts

- **NCT ID:** NCT02081053
- **Lead sponsor:** DFINE Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-01
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** Difficulty Enrolling
- **Last updated:** 2017-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02081053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02081053, "Evaluating Clinical Outcomes of Targeted Radiofrequency Ablation and Kyphoplasty (Also Known as Vertebral Augmentation) to Treat Painful Metastatic Vertebral Body Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02081053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*